Clearpoint Neuro Inc
CLPT10.530USD
+0.530+5.30%
收盤 08/04, 16:00（美東）報價延遲15分鐘
294.63M總市值
虧損本益比TTM
關於 Clearpoint Neuro Inc 公司
ClearPoint Neuro, Inc. 是一家全球設備、細胞和基因治療公司，爲大腦和脊柱提供精確導航。該公司提供臨牀產品以及受控藥物和設備輸送的臨牀前開發服務。該公司的旗艦產品是 ClearPoint Neuro 導航系統。其首款產品 ClearPoint 系統是一個由資本設備和一次性產品組成的集成系統，旨在允許在磁共振成像 (MRI) 套件中對大腦進行微創手術。ClearPoint Array Neuro 導航系統及其主要一次性組件旨在部署在手術室環境中，同時也可用於 MRI 套件。它與北美、歐洲、亞洲和南美的醫療保健和研究中心合作。它還爲全球臨牀前研究和臨牀試驗中直接向中樞神經系統輸送治療劑提供解決方案。
公司簡介
公司代碼CLPT
公司名稱Clearpoint Neuro Inc
上市日期Jul 03, 2019
CEOMr. Joseph Michael Burnett
員工數量115
證券類型Ordinary Share
年結日Jul 03
公司地址120 S. Sierra Avenue
城市SOLANA BEACH
上市交易所NASDAQ Capital Market Consolidated
國家United States of America
郵編92075
電話19499006833
網址https://www.clearpointneuro.com/
公司代碼CLPT
上市日期Jul 03, 2019
CEOMr. Joseph Michael Burnett
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Joseph Michael Burnett
Mr. Joseph Michael Burnett
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
276.08K
-4.84%
Mr. Timothy T. Richards
Mr. Timothy T. Richards
Independent Director
Independent Director
78.31K
+1.21%
Mr. Mazin Sabra
Mr. Mazin Sabra
Chief Operating Officer
Chief Operating Officer
51.56K
+0.71%
Dr. Matthew B. Klein, M.D.
Dr. Matthew B. Klein, M.D.
Independent Director
Independent Director
50.52K
+71.68%
Ms. Lynnette C. Fallon
Ms. Lynnette C. Fallon
Independent Director
Independent Director
40.90K
-19.96%
Mr. Danilo D' Alessandro
Mr. Danilo D' Alessandro
Chief Financial Officer
Chief Financial Officer
--
--
Ms. B. Kristine (Kris) Johnson
Ms. B. Kristine (Kris) Johnson
Independent Director
Independent Director
--
--
Dr. Linda M. Liau
Dr. Linda M. Liau
Independent Director
Independent Director
--
--
Mr. Jeremy L. Stigall
Mr. Jeremy L. Stigall
Chief Business Officer
Chief Business Officer
--
--
Mr. R. John Fletcher
Mr. R. John Fletcher
Independent Chairman of the Board
Independent Chairman of the Board
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Joseph Michael Burnett
Mr. Joseph Michael Burnett
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
276.08K
-4.84%
Mr. Timothy T. Richards
Mr. Timothy T. Richards
Independent Director
Independent Director
78.31K
+1.21%
Mr. Mazin Sabra
Mr. Mazin Sabra
Chief Operating Officer
Chief Operating Officer
51.56K
+0.71%
Dr. Matthew B. Klein, M.D.
Dr. Matthew B. Klein, M.D.
Independent Director
Independent Director
50.52K
+71.68%
Ms. Lynnette C. Fallon
Ms. Lynnette C. Fallon
Independent Director
Independent Director
40.90K
-19.96%
Mr. Danilo D' Alessandro
Mr. Danilo D' Alessandro
Chief Financial Officer
Chief Financial Officer
--
--
收入明細
單位: USD更新時間: 7月6日 週日
單位: USD更新時間: 7月6日 週日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
Products: Functional neurosurgery
3.28M
38.62%
Services: Biologics and drug delivery
2.91M
34.31%
Products: Biologics and drug delivery
1.78M
20.98%
Services: Capital equipment and other
283.00K
3.34%
Product Systems and software products
234.00K
2.76%
地區USD
名稱
營收
佔比
United States
8.48M
100.00%
業務
地區
業務USD
名稱
營收
佔比
Products: Functional neurosurgery
3.28M
38.62%
Services: Biologics and drug delivery
2.91M
34.31%
Products: Biologics and drug delivery
1.78M
20.98%
Services: Capital equipment and other
283.00K
3.34%
Product Systems and software products
234.00K
2.76%
股東統計
更新時間: 5月15日 週四
更新時間: 5月15日 週四
持股股東
股東類型
持股股東
持股股東
佔比
The Vanguard Group, Inc.
5.22%
District 2 Capital LP
4.01%
PTC Therapeutics Inc
3.17%
Millennium Management LLC
2.62%
Susquehanna International Group, LLP
1.71%
Other
83.27%
持股股東
持股股東
佔比
The Vanguard Group, Inc.
5.22%
District 2 Capital LP
4.01%
PTC Therapeutics Inc
3.17%
Millennium Management LLC
2.62%
Susquehanna International Group, LLP
1.71%
Other
83.27%
股東類型
持股股東
佔比
Investment Advisor
15.28%
Hedge Fund
11.69%
Investment Advisor/Hedge Fund
5.88%
Individual Investor
5.24%
Corporation
3.17%
Research Firm
2.22%
Pension Fund
0.16%
Other
56.37%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
224
12.34M
43.65%
-23.48K
2025Q1
230
12.08M
42.76%
-158.33K
2024Q4
216
11.35M
41.09%
+117.64K
2024Q3
204
10.32M
38.18%
-558.62K
2024Q2
199
10.56M
39.44%
-945.58K
2024Q1
197
10.90M
40.86%
+64.32K
2023Q4
197
9.84M
39.93%
-1.22M
2023Q3
198
9.05M
36.76%
-2.10M
2023Q2
200
8.72M
35.43%
-782.48K
2023Q1
206
7.92M
32.20%
-48.15K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
The Vanguard Group, Inc.
1.28M
4.54%
+35.59K
+2.85%
Mar 31, 2025
District 2 Capital LP
1.13M
4.01%
+715.76K
+170.85%
Mar 31, 2025
PTC Therapeutics Inc
894.58K
3.17%
--
--
Aug 23, 2024
Millennium Management LLC
741.19K
2.62%
+452.04K
+156.34%
Mar 31, 2025
Susquehanna International Group, LLP
482.37K
1.71%
-26.79K
-5.26%
Mar 31, 2025
Bigger Capital Funds, LP
422.40K
1.49%
-688.79K
-61.99%
Mar 31, 2025
Bigger (Michael)
378.69K
1.34%
+20.00K
+5.58%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
368.02K
1.3%
-174.00
-0.05%
Mar 31, 2025
Brown Advisory
331.10K
1.17%
-2.30K
-0.69%
Mar 31, 2025
Essex Investment Management Company, LLC
327.46K
1.16%
-81.36K
-19.90%
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
iShares Neuroscience and Healthcare ETF
0.71%
Invesco NASDAQ Future Gen 200 ETF
0.46%
iShares Micro-Cap ETF
0.07%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.06%
Motley Fool Next Index ETF
0.02%
Invesco Russell 2000 Dynamic Multifactor ETF
0.02%
iShares Russell 2000 Growth ETF
0.02%
iShares Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
ProShares UltraPro Russell2000
0.01%
查看更多
iShares Neuroscience and Healthcare ETF
佔比0.71%
Invesco NASDAQ Future Gen 200 ETF
佔比0.46%
iShares Micro-Cap ETF
佔比0.07%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
佔比0.06%
Motley Fool Next Index ETF
佔比0.02%
Invesco Russell 2000 Dynamic Multifactor ETF
佔比0.02%
iShares Russell 2000 Growth ETF
佔比0.02%
iShares Russell 2000 ETF
佔比0.01%
Proshares Ultra Russell 2000
佔比0.01%
ProShares UltraPro Russell2000
佔比0.01%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
